SCHEMBL24079372

SCHEMBL24079372

CCc1cc2cc3cc(F)ccc3cc2cc1Br

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.41
CYP2A6 P11509 1/20 0.41
SLC6A4 P31645 4/20 0.35
SLC6A3 Q01959 3/20 0.35
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
PDE10A Q9Y233 1/20 0.33
PKM P14618 3/20 0.33
GABRA1 P14867 1/20 0.32
GABRB2 P47870 1/20 0.32
MAPT P10636 2/20 0.32
PTPN1 P18031 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HTR2A P28223 1/20 0.31
KCNH2 Q12809 1/20 0.31
TSHR P16473 1/20 0.31
HTT P42858 1/20 0.31
DAO P14920 1/20 0.31
P2RX7 Q99572 2/20 0.31
BACE1 P56817 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24079375 0.78 GABRA1 (0.37) CYP1A2CYP2A6SLC6A4SLC6A3PDE10A
SCHEMBL22877463 0.77 CYP2A6 (0.45) CYP1A2CYP2A6GABRA1GABRB2MAPT
SCHEMBL322033 0.77 GABRA1 (0.39) SLC6A4MEN1KMT2APKMGABRA1
SCHEMBL3711398 0.77 PKM (0.42) MEN1KMT2APKMGABRA1GABRB2
SCHEMBL30005666 0.77 PKM (0.42) MEN1KMT2APKMGABRA1GABRB2
SCHEMBL3828830 0.73 CYP1A2 (0.68) CYP1A2CYP2A6SLC6A4SLC6A3KCNH2
SCHEMBL11303205 0.73 CYP1A2 (0.68) CYP1A2CYP2A6SLC6A4SLC6A3KCNH2
SCHEMBL23039158 0.71 AMY1A (0.43) CYP1A2CYP2A6MEN1KMT2APKM
SCHEMBL23060864 0.71 AMY1A (0.43) CYP1A2CYP2A6MEN1KMT2APKM
SCHEMBL24079354 0.70 CYP1A2 (0.41) CYP1A2CYP2A6SLC6A4PKMMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192881-B2 Compound for organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2021-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11192881-B2 Compound for organic electroluminescence device using the same OR10J3, KCNH1, SLCO4C1 CYP1A2 691/4885CYP2A6 1813/4885SLC6A4 1404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.